Vertaling van "–317 28 –323 –289 of which " (Nederlands → Frans) :

Other Income & Expense –201 –226 –11 –16 –36 –44 –24 –7 –51 –24 –323 –317 28 –323 –289 Of which amortization and impairments of capitalized intangible assets included in function costs –33 –257 –6 –7 –5 –2 –1 –44 –267 –44 –267
Autres produits et charges –201 –226 –11 –16 –36 –44 –24 –7 –51 –24 –323 –317 28 –323 –289 dont amortissements et pertes de valeur sur immobilisations incorporelles capitalisées

1 1 N06AB SELECTIEVE SEROTONINE REUPTAKE INHIBITOREN 4,8% 3.610.510 73.789 2,9% 5 5 2 2 C09AA INHIBITOREN VAN HET ANGIOTENSINE-CONVERSIE-ENZYM (ACE), ENKELVOUDIG 4,4% 3.255.933 127.361 5,1% 2 2 3 3 C08CA DIHYDROPYRIDINEDERIVATEN 4,1% 3.062.323 95.102 3,8% 4 4 4 4 A02BC INHIBITOREN VAN DE PROTONPOMP 4,0% 2.986.506 35.132 1,4% 21 28 5 7 C10AA HMG-CoA REDUCTASEREMMERS 3,9% 2.895.866 58.064 2,3% 8 20 6 5 R03BA GLUCOCORTICOIDEN 3,6% 2.728.243 59.956 2,4% 6 8 7 6 C07AB BETA-RECEPTORBLOKKERENDE MIDDELEN, SELECTIEVE 3,1% 2.350.830 119.078 4,7% 3 3 8 8 J01CR COMBINATIEPREPARATEN VAN PENICILLINES, INCL. BETALACTAMASE-REMMERS 2,6% 1.961.366 19.251 0,8% 38 39 9 9 J01DA CEFALOSPORINES EN VERWANTE VERBINDINGEN 2,4% 1.766.549 10.325 0,4% 57 59 10 10 J01FA MACROLIDEN 2,3% 1.708.109 13.256 0,5% 50 52 11 11 C10AB FIBRATEN 1,9% 1.444.367 59.936 2,4% 7 6 12 12 M01AC OXICAMDERIVATEN 1,9% 1.394.339 45.031 1,8% 18 14 13 13 G03AA PROGESTAGENEN MET OESTROGENEN IN VASTE VERHOUDING 1,8% 1.372.470 189.857 7,6% 1 1 14 17 C01DX OVERIGE VASODILATANTIA BIJ HARTZIEKTEN 1,6% 1.182.235 54.628 2,2% 10 17 15 15 J01CA PENICILLINES MET BREED SPECTRUM 1,5% 1.147.071 15.188 0,6% 46 44 16 16 J01MA FLUOROCHINOLONEN 1,5% 1.138.496 6.890 0,3% 75 72 17 14 A02BA H2-RECEPTORBLOKKERENDE MIDDELEN 1,5% 1.117.991 17.273 0,7% 41 37 18 22 J02AC TRIAZOLDERIVATEN 1,4% 1.034.930 3.591 0,1% 101 102 19 21 N02AX OVERIGE OPIOIDEN 1,4% 1.019.182 13.270 0,5% 49 51 20 24 L02AE GONADORELINE-ANALOGEN 1,3% 988.978 4.012 0,2% 96 99 21 26 B01AB HEPARINEGROEP 1,3% 964.483 6.822 0,3% 76 82 22 20 H02AB GLUCOCORTICOIDEN 1,3% 949.909 45.388 1,8% 15 16 23 33 N06AX OVERIGE ANTIDEPRESSIVA 1,3% 938.452 22.083 0,9% 36 45 24 18 C01DA ORGANISCHE NITRATEN 1,2% 928.536 49.584 2,0% 12 9 25 19 M01AE PROPIONZUURDERIVATEN 1,2% 892.750 45.180 1,8% 17 13 26 25 A10BB SULFONYLUREUMDERIVATEN 1,2% 890.183 46.084 1,8% 14 15 27 27 M01AB AZIJNZUURDERIVATEN EN VERWANTE STOFFEN 1,2% 889.447 34.544 1,4% 22 24 28 23 J01AA TETRACYCLINES 1,1% 837.977 15.485 0,6% 43 ...
1 1 N06AB INHIBITEURS SELECTIFS DU RECAPTAGE DE LA SEROTONINE 4,8% 3.610.510 73.789 2,9% 5 5 2 2 C09AA INHIBITEURS DE L'ENZYME DE CONVERSION DE L'ANGIOTENSINE (ECA), SIMPLES 4,4% 3.255.933 127.361 5,1% 2 2 3 3 C08CA DERIVES DE LA DIHYDROPYRIDINE 4,1% 3.062.323 95.102 3,8% 4 4 4 4 A02BC INHIBITEURS DE LA POMPE A PROTONS 4,0% 2.986.506 35.132 1,4% 21 28 5 7 C10AA INHIBITEURS DE LA HMG-CoA REDUCTASE 3,9% 2.895.866 58.064 2,3% 8 20 6 5 R03BA GLUCOCORTICOIDES 3,6% 2.728.243 59.956 2,4% 6 8 7 6 C07AB BETA-BLOQUANTS SELECTIFS 3,1% 2.350.830 119.078 4,7% 3 3 8 8 J01CR ASSOCIATIONS DE PENICILLINES, INHIB. DE LA BETALACTAMASE INCLUS 2,6% 1.961.366 19.251 0,8% 38 39 9 9 J01DA CEPHALOSPORINES ET APPARENTES 2,4% 1.766.549 10.325 0,4% 57 59 10 10 J01FA MACROLIDES 2,3% 1.708.109 13.256 0,5% 50 52 11 11 C10AB FIBRATEN 1,9% 1.444.367 59.936 2,4% 7 6 12 12 M01AC OXICAMES 1,9% 1.394.339 45.031 1,8% 18 14 13 13 G03AA PROGESTATIFS ET ESTROGENES, ASSOCIATIONS FIXES 1,8% 1.372.470 189.857 7,6% 1 1 14 17 C01DX AUTRES VASODILATATEURS POUR MALADIES CARDIAQUES 1,6% 1.182.235 54.628 2,2% 10 17 15 15 J01CA PENICILLINES A LARGE SPECTRE 1,5% 1.147.071 15.188 0,6% 46 44 16 16 J01MA FLUOROQUINOLONES 1,5% 1.138.496 6.890 0,3% 75 72 17 14 A02BA ANTIHISTAMINIQUES H2 1,5% 1.117.991 17.273 0,7% 41 37 18 22 J02AC DERIVES TRIAZOLES 1,4% 1.034.930 3.591 0,1% 101 102 19 21 N02AX AUTRES OPIACES 1,4% 1.019.182 13.270 0,5% 49 51 20 24 L02AE ANALOGUES DE LA GONADORELINE 1,3% 988.978 4.012 0,2% 96 99 21 26 B01AB HEPARINE 1,3% 964.483 6.822 0,3% 76 82 22 20 H02AB GLUCOCORTICOIDES 1,3% 949.909 45.388 1,8% 15 16 23 33 N06AX AUTRES ANTIDEPRESSEURS 1,3% 938.452 22.083 0,9% 36 45 24 18 C01DA NITRATES ORGANIQUES 1,2% 928.536 49.584 2,0% 12 9 25 19 M01AE DERIVES DE L'ACIDE PROPIONIQUE 1,2% 892.750 45.180 1,8% 17 13 26 25 A10BB DERIVES DE LA SULFONYLUREE 1,2% 890.183 46.084 1,8% 14 15 27 27 M01AB DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES 1,2% 889.447 34.544 1,4% 22 24 28 23 J01AA TETRACYCLINES 1,1% 837.977 15 ...

1 R03BA R03BA05 FLUTICASON 56.447 5,1% 1.536,0 R03BA02 BUDESONIDE 47.178 2,9% 849,9 R03BA01 BECLOMETASON 4.153 1,9% 139,6 R03BA03 FLUNISOLIDE 299 1,5% 10,5 2 R03AC R03AC12 SALMETEROL 28.352 6,0% 608,4 R03AC13 FORMOTEROL 6.957 6,9% 149,3 R03AC02 SALBUTAMOL 6.174 2,3% 495,5 R03AC04 FENOTEROL 1.304 1,9% 293,1 R03AC08 PIRBUTEROL 133 2,4% 18,3 R03AC03 TERBUTALINE 33 0,7% 5,3 3 H02AB H02AB04 METHYLPREDNISOLON 15.280 2,4% 929,0 H02AB01 BETAMETHASON 688 0,4% 39,7 H02AB06 PREDNISOLON 81 0,4% 10,9 H02AB08 TRIAMCINOLON 66 0,1% 1,2 H02AB09 HYDROCORTISON 21 0,3% 1,1 H02AB02 DEXAMETHASON 8 0,1% 0,8 H02AB10 CORTISON 4 0,2% 0,2 H02AB07 PREDNISON 2 0,4% 0,2 4 R03AK R03AK03 FENOTEROL MET ANDERE ASTMAMID. 15. 830 2,5% 999,5 R03AK04 SALBUTAMOL MET ANDERE ASTMAMIDDELEN 28 3,8% 1,3 5 R05CB R05CB01 ACETYLCYSTEINE 4.803 1,8% 264,4 R05CB13 DORNASE ALFA (DESOXYRIBONUCLEASE) 2.313 3,7% 2,6 R05CB05 MESNA 907 1,4% 7,1 6 L04AA L04AA01 CICLOSPORINE 4.412 0,7% 11,0 L04AA05 TACROLIMUS 3.323 2,5% 6,4 L04AA06 MYCOFENOLZUUR 65 0,1% 0,2 7 A02BC A02BC01 OMEPRAZOL 5.075 0,2% 59,4 A02BC03 LANSOPRAZOL 1.327 0,1% 16,4 A02BC02 PANTOPRAZOL 193 0,2% 2,5 8 J01FA J01FA09 CLARITROMYCINE 4.974 0,6% 43,3 J01FA10 AZITROMYCINE 642 0,2% 4,1 J01FA06 ROXITROMYCINE 403 0,1% 2,9 J01FA11 MIOCAMYCINE 311 0,3% 3,1 J01FA13 DIRITHROMYCINE 101 0,4% 0,7 J01FA01 ERYTROMYCINE 98 0,2% 0,8 J01FA02 SPIRAMYCINE 24 0,1% 0,2 J01FA04 PRISTINAMYCINE 1 0,1% 0,0 9 R01AD R01AD05 BUDESONIDE 4.781 1,8% 286,1 R01AD01 BECLOMETASON 899 0,9% 48,9 R01AD08 FLUTICASON 641 2,1% 32,5 R01AD04 FLUNISOLIDE 138 0,6% 11,9 R01AD07 TIXOCORTOL 7 0,4% 0,5 10 R06AX R06AX17 KETOTIFEN 3.015 1,6% 116,6 R06AX13 LORATADINE 1.174 0,7% 51,5 R06AX26 FEXOFENADINE 989 1,6% 43,5 R06AX22 EBASTINE 651 1,8% 28,6 R06AX25 MIZOLASTINE 178 1,0% 7,4 R06AX11 ASTEMIZOL 113 1,4% 4,8 R06AX12 TERFENADINE 98 1,0% 4,2 11 R03BB R03BB01 IPRATROPIUM BROMIDE 3.736 2,1% 508,5 R03BB02 OXITROPIUM BROMIDE 2.289 4,2% 157,7 12 J01DA J01DA06 CEFUROXIM 4.601 0,6% 50,9 J01DA08 CEFACLOR 632 0,1% 8,5 J ...
1 R03BA R03BA05 FLUTICASONE 56.447 5,1% 1.536,0 R03BA02 BUDESONIDE 47.178 2,9% 849,9 R03BA01 BECLOMETHASONE 4.153 1,9% 139,6 R03BA03 FLUNISOLIDE 299 1,5% 10,5 2 R03AC R03AC12 SALMETEROL 28.352 6,0% 608,4 R03AC13 FORMOTEROL 6.957 6,9% 149,3 R03AC02 SALBUTAMOL 6.174 2,3% 495,5 R03AC04 FENOTEROL 1.304 1,9% 293,1 R03AC08 PIRBUTEROL 133 2,4% 18,3 R03AC03 TERBUTALINE 33 0,7% 5,3 3 H02AB H02AB04 METHYLPREDNISOLONE 15.280 2,4% 929,0 H02AB01 BETAMETHASONE 688 0,4% 39,7 H02AB06 PREDNISOLONE 81 0,4% 10,9 H02AB08 TRIAMCINOLONE 66 0,1% 1,2 H02AB09 HYDROCORTISONE 21 0,3% 1,1 H02AB02 DEXAMETHASONE 8 0,1% 0,8 H02AB10 CORTISONE 4 0,2% 0,2 H02AB07 PREDNISONE 2 0,4% 0,2 4 R03AK R03AK03 FENOTEROL ET AUTRES ANTIASTHMAT. 15. 830 2,5% 999,5 R03AK04 SALBUATMOL ET AUTRES ANTIASTHMATIQUES 28 3,8% 1,3 5 R05CB R05CB01 ACETYLCYSTEINE 4.803 1,8% 264,4 R05CB13 DORNASE ALFA (DESOXYRIBONUCLEASE) 2.313 3,7% 2,6 R05CB05 MESNA 907 1,4% 7,1 6 L04AA L04AA01 CICLOSPORINE 4.412 0,7% 11,0 L04AA05 TACROLIMUS 3.323 2,5% 6,4 L04AA06 ACIDE MYCOPHENOLIQUE 65 0,1% 0,2 7 A02BC A02BC01 OMEPRAZOLE 5.075 0,2% 59,4 A02BC03 LANSOPRAZOLE 1.327 0,1% 16,4 A02BC02 PANTOPRAZOLE 193 0,2% 2,5 8 J01FA J01FA09 CLARITHROMYCINE 4.974 0,6% 43,3 J01FA10 AZITHROMYCINE 642 0,2% 4,1 J01FA06 ROXITHROMYCINE 403 0,1% 2,9 J01FA11 MIOCAMYCINE 311 0,3% 3,1 J01FA13 DIRITHROMYCINE 101 0,4% 0,7 J01FA01 ERYTHROMYCINE 98 0,2% 0,8 J01FA02 SPIRAMYCINE 24 0,1% 0,2 J01FA04 PRISTINAMYCINE 1 0,1% 0,0 9 R01AD R01AD05 BUDESONIDE 4.781 1,8% 286,1 R01AD01 BECLOMETHASONE 899 0,9% 48,9 R01AD08 FLUTICASONE 641 2,1% 32,5 R01AD04 FLUNISOLIDE 138 0,6% 11,9 R01AD07 TIXOCORTOL 7 0,4% 0,5 10 R06AX R06AX17 KETOTIFENE 3.015 1,6% 116,6 R06AX13 LORATADINE 1.174 0,7% 51,5 R06AX26 FEXOFENADINE 989 1,6% 43,5 R06AX22 EBASTINE 651 1,8% 28,6 R06AX25 MIZOLASTINE 178 1,0% 7,4 R06AX11 ASTEMIZOLE 113 1,4% 4,8 R06AX12 TERFENADINE 98 1,0% 4,2 11 R03BB R03BB01 BROMURE D'IPRATROPIUM 3.736 2,1% 508,5 R03BB02 BROMURE D'OXITROPIUM 2.289 4,2% 157,7 12 J01DA J01DA06 CEFUROXIME 4.601 0, ...

jaar 2000 101.653.250,76 4,6% 102.301.852,38 4,7% 103.178.896,83 4,5% 106.924.597,43 4,1% 84.049.345,09 3,1% jaar 2001 222.020.492,17 10,1% 200.837.869,58 9,3% 208.476.465,56 9,1% 223.423.447,06 8,6% 211.891.293,09 7,9% jaar 2002 428.182.463,39 19,4% 400.615.034,66 18,5% 389.923.033,50 17,0% 433.220.402,40 16,6% 431.169.454,98 16,1% jaar 2003 261.017.432,94 11,8% 269.134.257,97 12,4% 283.197.072,28 12,3% 289.251.643,28 11,1% 265.702.381,48 9,9% jaar 2004 190.967.617,42 8,7% 212.673.306,49 9,8% 237.252.963,14 10,3% 276.876.788,72 10,6% 297.141.541,41 11,1% jaar 2005 28.447.212,43 1,3% 127.045.065,73 5,9% 164.057.732,51 7,1% 190.339.294,46 7,3% 191.410.965,71 7,1% jaar 2006 30.746.721,41 1,4% 92.764.705,85 4,0% 117.947.907,47 4,5% 122.339.662,93 4,6% jaar 2007 27.215.273,72 1,2% 127.519.458,84 4,9% 149.933.477,71 5,6% jaar 2008 46.662.199,15 1,8% 140.491.100,70 5,2% jaar 2009 78.946.897,44 2,9% TOTAAL 2.206.159.935,74 100,0% 2.163.539.552,05 100,0% 2.295.550.665,61 100,0% 2.609.606.693,58 100,0% 2.684.317.428,25 100,0%
année 2000 101.653.250,76 4,6% 102.301.852,38 4,7% 103.178.896,83 4,5% 106.924.597,43 4,1% 84.049.345,09 3,1% année 2001 222.020.492,17 10,1% 200.837.869,58 9,3% 208.476.465,56 9,1% 223.423.447,06 8,6% 211.891.293,09 7,9% année 2002 428.182.463,39 19,4% 400.615.034,66 18,5% 389.923.033,50 17,0% 433.220.402,40 16,6% 431.169.454,98 16,1% année 2003 261.017.432,94 11,8% 269.134.257,97 12,4% 283.197.072,28 12,3% 289.251.643,28 11,1% 265.702.381,48 9,9% année 2004 190.967.617,42 8,7% 212.673.306,49 9,8% 237.252.963,14 10,3% 276.876.788,72 10,6% 297.141.541,41 11,1% année 2005 28.447.212,43 1,3% 127.045.065,73 5,9% 164.057.732,51 7,1% 190.339.294,46 7,3% 191.410.965,71 7,1% année 2006 30.746.721,41 1,4% 92.764.705,85 4,0% 117.947.907,47 4,5% 122.339.662,93 4,6% année 2007 27.215.273,72 1,2% 127.519.458,84 4,9% 149.933.477,71 5,6% année 2008 46.662.199,15 1,8% 140.491.100,70 5,2% année 2009 78.946.897,44 2,9% TOTAL 2.206.159.935,74 100,0% 2.163.539.552,05 100,0% 2.295.550.665,61 100,0% 2.609.606.693,58 100,0% 2.684.317.428,25 100,0%

M01AA PYRAZOLINONDERIVATEN 188.711 153.250 140.490 122.890 111.811 105.864 99.638 91.998 80.078 M01AB AZIJNZUURDERIVATEN EN VERWANTE STOFFEN 24.761.466 27.799.385 30.225.845 30.181.501 28.103.306 31.471.445 32.761.623 32.494.713 32.367.219 M01AC OXICAMDERIVATEN 36.014.984 36.106.203 36.333.060 36.033.620 31.101.626 33.769.107 34.355.440 33.494.595 32.632.072 M01AE PROPIONZUURDERIVATEN 34.497.220 33.609.518 33.392.636 31.447.146 28.689.935 29.347.628 29.657.445 29.377.752 30.353.744 M01AH COXIBS 0 0 0 0 289.893 12.834.446 14.296.868 16.811.251 6.622.144 M01AX OVERIGE NIET-STEROIDE ANTIINFLAMMATOIRE/ANTIRHEUMATISCHE MIDDELEN 6.317.931 5.952.410 5.735.478 7.449.105 8.175.153 8.929.640 8.303.175 8.569.905 9.131.655 Totaal 101.780.313 103.620.766 105.827.509 105.234.261 96.471.725 116.458.130 119.474.188 120.840.213 111.186.912
M01AA DERIVES DE LA PYRAZOLONE 188.711 153.250 140.490 122.890 111.811 105.864 99.638 91.998 80.078 M01AB DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES 24.761.466 27.799.385 30.225.845 30.181.501 28.103.306 31.471.445 32.761.623 32.494.713 32.367.219 M01AC OXICAMES 36.014.984 36.106.203 36.333.060 36.033.620 31.101.626 33.769.107 34.355.440 33.494.595 32.632.072 M01AE DERIVES DE L'ACIDE PROPIONIQUE 34.497.220 33.609.518 33.392.636 31.447.146 28.689.935 29.347.628 29.657.445 29.377.752 30.353.744 M01AH COXIBS 0 0 0 0 289.893 12.834.446 14.296.868 16.811.251 6.622.144 M01AX AUTRES ANTI-INFLAMMATOIRES/ANTIRHUMASTISMAUX NON STEROIDIENS 6.317.931 5.952.410 5.735.478 7.449.105 8.175.153 8.929.640 8.303.175 8.569.905 9.131.655 Total 101.780.313 103.620.766 105.827.509 105.234.261 96.471.725 116.458.130 119.474.188 120.840.213 111.186.912

N 3 0 3 2 1 0 1 9 0 6 3 0 14 5 % 0,1% 0,0% 0,1% 0,1% 0,1% 0,0% 0,6% 0,1% 0,0% 0,3% 0,1% 0,0% 0,1% N 17 0 17 19 11 2 6 34 3 10 7 14 70 6 % 0,4% 0,0% 0,4% 1,4% 1,3% 0,6% 3,4% 0,5% 0,9% 0,4% 0,3% 0,7% 0,6% N 177 0 177 64 34 23 7 237 14 76 96 51 478 7 % 4,4% 0,0% 4,4% 4,6% 3,9% 6,7% 3,9% 3,4% 4,2% 3,3% 3,8% 2,7% 3,8% N 473 1 472 134 94 28 12 705 32 213 263 197 1.312 8 % 11,8% 3,3% 11,9% 9,6% 10,7% 8,2% 6,7% 10,0% 9,6% 9,3% 10,3% 10,5% 10,5% N 417 1 416 116 69 28 19 672 27 223 235 187 1.205 9 % 10,4% 3,3% 10,4% 8,3% 7,9% 8,2% 10,6% 9,5% 8,1% 9,7% 9,2% 9,9% 9,7% N 553 5 548 199 123 53 23 1.062 55 354 387 266 1.814 10 % 13,8% 16,7% 13,8% 14,2% 14,0% 15,5% 12,8% 15,0% 16,6% 15,4% 15,1% 14,1% 14,5% N 556 9 547 179 118 44 17 887 35 286 332 234 1.622 11 % 13,9% 30,0% 13,7% 12,8% 13,4% 12,8% 9,5% 12,6% 10,5% 12,5% 13,0% 12,4% 13,0% N 112 1 111 46 31 8 7 238 6 92 76 64 396 12 % 2,8% 3,3% 2,8% 3,3% 3,5% 2,3% 3,9% 3,4% 1,8% 4,0% 3,0% 3,4% 3,2% N 299 2 297 97 60 30 7 483 25 139 188 131 879 13 % 7,5% 6,7% 7,5% 6,9% 6,8% 8,7% 3,9% 6,8% 7,5% 6,1% 7,4% 7,0% 7,0% N 490 3 487 185 106 49 30 861 35 317 303 206 1.536 14 % 12,2% 10,0% 12,2% 13,2% 12,1% 14,3% 16,8% 12,2% 10,5% 13,8% 11,9% 11,0% 12,3% 15 N 504 3 501 166 105 41 20 887 54 276 323 234 1.557
N 12 0 12 7 2 2 3 38 2 24 6 6 57 0 % 0,3% 0,0% 0,3% 0,5% 0,2% 0,6% 1,7% 0,5% 0,6% 1,0% 0,2% 0,3% 0,5% N 2 0 2 4 4 0 0 8 1 6 0 1 14 1 % 0,0% 0,0% 0,1% 0,3% 0,5% 0,0% 0,0% 0,1% 0,3% 0,3% 0,0% 0,1% 0,1% N 0 0 0 4 3 1 0 3 1 0 0 2 7 2 % 0,0% 0,0% 0,0% 0,3% 0,3% 0,3% 0,0% 0,0% 0,3% 0,0% 0,0% 0,1% 0,1% N 0 0 0 4 3 0 1 6 0 3 1 2 10 3 % 0,0% 0,0% 0,0% 0,3% 0,3% 0,0% 0,6% 0,1% 0,0% 0,1% 0,0% 0,1% 0,1% N 0 0 0 2 2 0 0 1 0 0 0 1 3 4 % 0,0% 0,0% 0,0% 0,1% 0,2% 0,0% 0,0% 0,0% 0,0% 0,0% 0,0% 0,1% 0,0% N 3 0 3 2 1 0 1 9 0 6 3 0 14 5 % 0,1% 0,0% 0,1% 0,1% 0,1% 0,0% 0,6% 0,1% 0,0% 0,3% 0,1% 0,0% 0,1% N 17 0 17 19 11 2 6 34 3 10 7 14 70 6 % 0,4% 0,0% 0,4% 1,4% 1,3% 0,6% 3,4% 0,5% 0,9% 0,4% 0,3% 0,7% 0,6% N 177 0 177 64 34 23 7 237 14 76 96 51 478 7 % 4,4% 0,0% 4,4% 4,6% 3,9% 6,7% 3,9% 3,4% 4,2% 3,3% 3,8% 2,7% 3,8% N 473 1 472 134 94 28 12 705 32 213 263 197 1.312 8 % 11,8% 3,3% 11,9% 9,6% 10,7% 8,2% 6,7% 10,0% 9,6% 9,3% 10,3% 10,5% 10,5% 9 N 417 1 416 116 69 28 19 672 27 223 235 187 1.205

M01AA PYRAZOLINONDERIVATEN 188.711 153.250 140.490 122.890 111.811 105.864 99.638 91.998 M01AB AZIJNZUURDERIVATEN EN VERWANTE STOFFEN 24.761.466 27.799.385 30.225.845 30.181.501 28.103.306 31.471.445 32.761.623 32.494.713 M01AC OXICAMDERIVATEN 36.014.984 36.106.203 36.333.060 36.033.620 31.101.626 33.769.107 34.355.440 33.494.595 M01AE PROPIONZUURDERIVATEN 34.497.220 33.609.518 33.392.636 31.447.146 28.689.935 29.347.628 29.657.445 29.377.752 M01AH COXIBS 0 0 0 0 289.893 12.834.446 14.296.868 16.811.251 M01AX OVERIGE NIET-STEROIDE ANTIINFLAMMATOIRE/ANTIRHEUMATISCHE MIDDELEN 6.317.931 5.952.410 5.735.478 7.449.105 8.175.153 8.929.640 8.303.175 8.569.905 Totaal 101.780.313 103.620.766 105.827.509 105.234.261 96.471.725 116.458.130 119.474.188 120.840.213
M01AA DERIVES DE LA PYRAZOLONE 188.711 153.250 140.490 122.890 111.811 105.864 99.638 91.998 M01AB DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES 24.761.466 27.799.385 30.225.845 30.181.501 28.103.306 31.471.445 32.761.623 32.494.713 M01AC OXICAMES 36.014.984 36.106.203 36.333.060 36.033.620 31.101.626 33.769.107 34.355.440 33.494.595 M01AE DERIVES DE L'ACIDE PROPIONIQUE 34.497.220 33.609.518 33.392.636 31.447.146 28.689.935 29.347.628 29.657.445 29.377.752 M01AH COXIBS 0 0 0 0 289.893 12.834.446 14.296.868 16.811.251 M01AX AUTRES ANTI-INFLAMMATOIRES/ANTIRHUMASTISMAUX NON STEROIDIENS 6.317.931 5.952.410 5.735.478 7.449.105 8.175.153 8.929.640 8.303.175 8.569.905 Total 101.780.313 103.620.766 105.827.509 105.234.261 96.471.725 116.458.130 119.474.188 120.840.213

M01AA PYRAZOLINONDERIVATEN 188.711 153.250 140.490 122.890 111.811 105.864 99.638 91.998 80.078 79.265 M01AB AZIJNZUURDERIVATEN EN VERWANTE STOFFEN 24.761.466 27.799.385 30.225.845 30.181.501 28.103.306 31.471.445 32.761.623 32.494.713 32.367.219 32.945.561 M01AC OXICAMDERIVATEN 36.014.984 36.106.203 36.333.060 36.033.620 31.101.626 33.769.107 34.355.440 33.494.595 32.632.072 32.058.748 M01AE PROPIONZUURDERIVATEN 34.497.220 33.609.518 33.392.636 31.447.146 28.689.935 29.347.628 29.657.445 29.377.752 30.353.744 30.703.691 M01AH COXIBS 0 0 0 0 289.893 12.834.446 14.296.868 16.811.251 6.622.144 0 M01AX OVERIGE NIET-STEROIDE ANTIINFLAMMATOIRE/ANTIRHEUMATISCHE MIDDELEN 6.317.931 5.952.410 5.735.478 7.449.105 8.175.153 8.929.640 8.303.175 8.569.905 9.131.655 9.554.145 Totaal 101.780.313 103.620.766 105.827.509 105.234.261 96.471.725 116.458.130 119.474.188 120.840.213 111.186.912 105.341.409
M01AA DERIVES DE LA PYRAZOLONE 188.711 153.250 140.490 122.890 111.811 105.864 99.638 91.998 80.078 79.265 M01AB DERIVES DE L'ACIDE ACETIQUE ET SUBSTANCES APPARENTEES 24.761.466 27.799.385 30.225.845 30.181.501 28.103.306 31.471.445 32.761.623 32.494.713 32.367.219 32.945.561 M01AC OXICAMES 36.014.984 36.106.203 36.333.060 36.033.620 31.101.626 33.769.107 34.355.440 33.494.595 32.632.072 32.058.748 M01AE DERIVES DE L'ACIDE PROPIONIQUE 34.497.220 33.609.518 33.392.636 31.447.146 28.689.935 29.347.628 29.657.445 29.377.752 30.353.744 30.703.691 M01AH COXIBS 0 0 0 0 289.893 12.834.446 14.296.868 16.811.251 6.622.144 0 M01AX AUTRES ANTI-INFLAMMATOIRES/ANTIRHUMASTISMAUX NON STEROIDIENS 6.317.931 5.952.410 5.735.478 7.449.105 8.175.153 8.929.640 8.303.175 8.569.905 9.131.655 9.554.145 Total 101.780.313 103.620.766 105.827.509 105.234.261 96.471.725 116.458.130 119.474.188 120.840.213 111.186.912 105.341.409

C10AA04 FLUVASTATINE 24 0,4% 47,6 15 N04BA N04BA02 LEVODOPA MET DECARBOXYLASEREMMER 920 13,6% 959,7 N04BA03 LEVODOPA MET DECARBOXYLASEREMMER EN COMT-REM 226 51,2% 46,1 16 N03AF N03AF01 CARBAMAZEPINE 825 19,6% 1.319,7 N03AF02 OXCARBAZEPINE 249 28,6% 141,5 17 N05AD N05AD01 HALOPERIDOL 430 26,5% 685,9 N05AD06 BROOMPERIDOL 197 42,2% 212,3 N05AD05 PIPAMPERON 150 25,1% 289,5 N05AD07 BENPERIDOL 23 19,3% 46,9 N05AD03 MELPERON 7 2,8% 6,2 18 N04BX N04BX02 ENTACAPON 789 21,7% 161,6 19 B01AC B01AC04 CLOPIDOGREL 523 1,1% 249,5 B01AC30 COMBINATIEPREPARATEN 36 2,4% 61,8 B01AC05 TICLOPIDINE 28 0,6% 25,9 B01AC07 DIPYRIDAMOL 1 0,6% 2,2 20 N02AX N02AX02 TRAMADOL 323 1,2% 183,8 N02AX01 TILIDINE 175 1,3% 132,1 N02AX52 TRAMADOL, COMBINATIEPREPARATEN 6 0,4% 3,5
C10AA04 FLUVASTATINE 24 0,4% 47,6 15 N04BA N04BA02 LEVODOPA AVEC INHIBITEUR DE LA DECARBOXYLASE 920 13,6% 959,7 N04BA03 LEVODOPA AVEC INHIBITEUR DE LA DECARBOXYLASE ET 226 51,2% 46,1 16 N03AF N03AF01 CARBAMAZEPINE 825 19,6% 1.319,7 N03AF02 OXCARBAZEPINE 249 28,6% 141,5 17 N05AD N05AD01 HALOPERIDOL 430 26,5% 685,9 N05AD06 BROMPERIDOL 197 42,2% 212,3 N05AD05 PIPAMPERONE 150 25,1% 289,5 N05AD07 BENPERIDOL 23 19,3% 46,9 N05AD03 MELPERONE 7 2,8% 6,2 18 N04BX N04BX02 ENTACAPONE 789 21,7% 161,6 19 B01AC B01AC04 CLOPIDOGREL 523 1,1% 249,5 B01AC30 ASSOCIATIONS 36 2,4% 61,8 B01AC05 TICLOPIDINE 28 0,6% 25,9 B01AC07 DIPYRIDAMOLE 1 0,6% 2,2 20 N02AX N02AX02 TRAMADOL 323 1,2% 183,8 N02AX01 TILIDINE 175 1,3% 132,1 N02AX52 TRAMADOL, ASSOCIATIONS 6 0,4% 3,5

Other Income & Expense –135 –494 –11 –12 –42 –49 –1 –113 –128 –67 –317 –735 12 –28 –305 –763 Of which amortization and impairments of capitalized intangible assets included in function costs –52 –111 –9 –7 –3 –9 –6 –64 –133 –64 –133
Autres produits et charges –135 –494 –11 –12 –42 –49 –1 –113 –128 –67 –317 –735 12 –28 –305 –763 dont amortissements et pertes de valeur sur